Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Immune effector cells via paracrine and contact-dependent mechanisms refers to the physiological process by which the immune system identifies and destroys pathological cells, such as malignant or infected cells. Contact-dependent mechanisms involve the formation of an immunological synapse between effector cells (like CD8+ T cells or Natural Killer cells) and target cells, facilitating the directed release of cytotoxic granules containing perforin and granzymes (Janeway's Immunobiology, 9th ed.). Paracrine mechanisms involve the secretion of soluble mediators, such as Interferon-gamma and Tumor Necrosis Factor, which alter the local microenvironment and activate neighboring immune cells to amplify the response (Abbas et al., Cellular and Molecular Immunology). This dual approach is the fundamental basis for the efficacy of various immunotherapies, including checkpoint inhibitors, bispecific T-cell engagers (BiTEs), and CAR-T cell therapies (Nature Reviews Drug Discovery, 2019). While essential for host defense, excessive activation of these mechanisms can lead to severe systemic toxicities like Cytokine Release Syndrome (NCI Dictionary). This entry describes a complex cellular interaction and therapeutic modality rather than a single molecular target or receptor.
Activation and recruitment of immune effector cells (e.g., T cells, NK cells) to eliminate target cells through direct physical contact (immunological synapse) and the secretion of local signaling molecules (cytokines).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immune effector cells via paracrine and contact-dependent mechanisms.